Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
VolitionRx Schedules Full-Year 2015 Earnings Conference Call and Business Update for Friday, March 11, 2016 at 8:30am ET
2016-03-09 21:30
ImmunoMet Therapeutics Raises $5.2 million in a Series A Financing
2016-03-08 21:00
3SBio's PEG-irinotecan Wins IND Approval From China FDA
2016-03-07 17:24
WuXi AppTec's STA Subsidiary Opens New Campus in Changzhou
2016-03-04 21:00
3SBio Inc. Announces Expansion of its Leadership Team
2016-03-04 19:03
China Biologic Announces Pricing of Secondary Offering of Common Stock
2016-03-02 22:17
Prima BioMed and WuXi Biologics Announce First Dose of Chinese-Manufactured Biologic in EU Clinical Trial
2016-03-02 14:00
China Biologic Announces Secondary Offering of Common Stock
2016-03-02 06:52
Nanotechnology Accelerates the Evolution of Precision Medicine, Finds Frost & Sullivan
2016-03-02 03:28
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2016
2016-03-01 05:16
STC-Stem Cell Treatment & Research Institute Registers Local Patent for Method to Mass Produce Pluripotent Stem Cells Without Side Effects
2016-02-29 21:00
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2015
2016-02-26 06:00
JHL Biotech Announces Mechanical Completion of its Wuhan Biopharmaceutical Manufacturing Facility
2016-02-25 17:00
Veritas Genetics and WorldCare Partnership First to Integrate Next Generation Whole Genome Sequencing and World-Class Medical Second Opinion Services
2016-02-24 08:00
Value Based Healthcare Transformation Spurs Innovative Opportunities for Industry Participants
2016-02-23 22:35
PharmaEssentia Announces Phase II Results of P1101, an Innovative, Mono-pegylated Interferon in Patients with Chronic HCV Genotype 2 Infection
2016-02-23 11:08
PharmaEssentia Announces Phase II Results of P1101, an Innovative, Mono-pegylated Interferon in Patients with Chronic HCV Genotype 1 Infection
2016-02-23 11:04
Eco-friendly Food Packaging Material Created by Researchers from NUS Doubles Shelf-life of Food Products
2016-02-23 11:00
Aptuit and Icagen Agree to Strategic Alliance
2016-02-22 22:00
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2016 Financial Results
2016-02-22 20:00
1
381
382
383
384
385
452